← Back to patent-cliff list
CAS 2306275-33-0
6-((6-methoxypyridin-3-yl)methyl)-3,6-diazabicyclo[3.1.1]heptane
Codes: SELP-027
Application context (from source-drug indications)
Solid tumourSelpercatinibMedullary thyroid cancerSelpercatinibNon-small cell lung cancerSelpercatinibThyroid cancerSelpercatinib
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| Selpercatinib | Tier C — Watch / trade | 2032 |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
2,2-dimethyloxirane→4-(6-fluoropyridin-3-yl)-6-(2-hydroxy-2-methylpropoxy)pyrazolo[1,5-a]pyridine-3-carbonitrile→4-(6-fluoropyridin-3-yl)-6-hydroxypyrazolo[1,5-a]pyridine-3-carbonitrile→6-((6-methoxypyridin-3-yl)methyl)-3,6-diazabicyclo[3.1.1]heptane
Intermediates available on this site
No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.